If any of them used just ~2-3B to invest in or buy XXII that probably would have offset the loss in equity some just suffered and/or they probably could have seen a rise in PPS and an increase in shareholders equity. Maybe they tried and lowballed XXII's value?
What do you think?
"that's why BIG T has lost over $50 billion in value since FDA announcment. . Wonder if XXII could be worth 10 per cent of that lost value ??? A $5 Billion value would make XXII a homerun"
News 
Market Data 
Discover 
AI
